What this means
This is a plan for a study that has not started recruiting people yet. It does not show whether the treatment works or is safe.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 18–65 · 20 adults in a planned trial
- Where
- 1 site, including California
The science
- Registered title
- Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris
- Trial ID
- NCT04240535 ↗
- Phase
- PHASE 4
- Study type
- interventional
- Conditions
- Aging
- What is tested
- OnabotulinumtoxinA 50 UNT [Botox Cosmetic]
- Sponsor
- Amir Moradi MD, MBA
- Ages
- 18 Years to 65 Years
- Dates
- First posted Jan 27, 2020 · updated Jan 27, 2020
Registry summary
Single Center, Double Blind, Placebo- Controlled Study of 20 subjects with 10 active drug/10 placebo
Standardized baseline/pre-treatments and follow-up images will be taken.
Subjects will receive injection of either study drug or placebo to the Depressor Anguli Oris. Follow ups will occur at 2 weeks, 4 weeks, and 12 weeks.
Sites (1)
- Moradi MD, Vista, California, United States